BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Curto A, Iamello RG, Lynch EN, Galli A. Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies. World J Clin Cases 2025; 13(30): 109028 [PMID: 41113084 DOI: 10.12998/wjcc.v13.i30.109028]
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/109028.htm
Number Citing Articles
1
Mandea Matei, Gheorghe Liliana Simona. State-of-the-art Evaluation and Management of Hepatobiliary Diseases [Working Title]2026;  doi: 10.5772/intechopen.1016072
2
Abdellatif Bouayad. Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributionsWorld Journal of Clinical Cases 2026; 14(5): 115814 doi: 10.12998/wjcc.v14.i5.115814
3
Stanislav Kotlyarov. Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitisWorld Journal of Hepatology 2026; 18(6): 118902 doi: 10.4254/wjh.118902
4
Mandea Matei, Gheorghe Liliana Simona. State-of-the-art Evaluation and Management of Hepatobiliary Diseases [Working Title]2026;  doi: 10.5772/intechopen.1016073
5
Xavier Palomer, Ricardo Rodríguez-Calvo, Sandra García-Mateo, Walter Wahli, Manuel Vázquez-Carrera. The emerging role of PPARs in primary biliary cholangitisTrends in Molecular Medicine 2026;  doi: 10.1016/j.molmed.2026.05.008